China to India: Syringe Import Trade Route

The China to India Syringe corridor is one of India's established pharmaceutical import routes from China, with 7 shipments documented worth a combined $478.6K USD. The route is dominated by YUXI WALVAX BIOTECHNOLOGY CO., LTD., which alone accounts for roughly 97% of all import value, reflecting the consolidated nature of China's syringe export sector.

Across 3 active China suppliers, the average shipment value stands at $68.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with syringe's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 30.1%, placing it at rank #18 among India's top syringe import origins globally.

On the Indian buyer side, key Indian importers include G.C. CHEMIE PHARMIE LIMITED, POLY MEDICURE LIMITED , MYLAN LABORATORIES LIMITED . G.C. CHEMIE PHARMIE LIMITED is the single largest Indian importer with 2 shipments valued at $464.5K USD.

India's syringe imports from China are driven primarily by a handful of large-scale China manufacturers. YUXI WALVAX BIOTECHNOLOGY CO., LTD. with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — Indian buyers benefit from China supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — YUXI WALVAX BIOTECHNOLOGY CO., LTD., HUBEI NEW DESHENG MATERIALS , Tianjin Apocalypse Trading Company — together account for 100% of total trade value on this route. The average shipment value of $68.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as heparin for blood collection syringe(lithium heparin) and gadoxetate sodium injection eob.primovist inj.syringe - batch#jps5805- qty 5units (syringe) - 181.43mg/ml 10ml , suggesting that Indian buyers tend to consolidate orders across related product lines from the same China supplier.

On the buying side, G.C. CHEMIE PHARMIE LIMITED is the largest importer with 2 shipments worth $464.5K USD — representing 97% of all syringe imports from China on this route.